sitagliptin/metformin sandoz 50 mg/850 mg filmtabletta
sandoz hungária kft. - a szitagliptin; metformin-hidroklorid -
sitagliptin/metformin sandoz 50 mg/1000 mg filmtabletta
sandoz hungária kft. - a szitagliptin; metformin-hidroklorid -
sitagliptin/metformin 1 a pharma 50 mg/850 mg filmtabletta
1 a pharma gmbh - a szitagliptin; metformin-hidroklorid -
sitagliptin/metformin 1 a pharma 50 mg/1000 mg filmtabletta
1 a pharma gmbh - a szitagliptin; metformin-hidroklorid -
sitagliptin/metformin grindeks 50 mg/850 mg filmtabletta
as grindeks - a szitagliptin; metformin -
sitagliptin/metformin grindeks 50 mg/1000 mg filmtabletta
as grindeks - a szitagliptin; metformin -
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
sitagliptin accord
accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
sitagliptin/metformin teva 50 mg/850 mg filmtabletta
teva gyógyszergyár zrt. - a szitagliptin; metformin-hidroklorid -
sitagliptin/metformin teva 50 mg/1000 mg filmtabletta
teva gyógyszergyár zrt. - a szitagliptin; metformin-hidroklorid -